Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is ...
Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...
Australia-based radiopharmaceutical company Telix Pharmaceuticals has created a new radionuclide generator that could ...
Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers from Japan recently developed a new radioactive drug that ...
Researchers said alpha particles are promising therapies that target cancer while minimizing the damage to nearby healthy tissues.
MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated ...
Gold nanoparticles (AuNPs) have emerged as promising drug carriers for cancer therapy and targeted drug delivery but tracking ...
Achieves alignment with U.S. Food and Drug Administration (FDA) on regulatory path for potential accelerated approval of iopofosine I 131 as a treatment for Waldenström macroglobulinemia (WM) ...
The first clinical trial under the Cooperative Research and Development Agreement with the National Cancer Institute and ...
Brookline Capital Management upgraded shares of Perspective Therapeutics (NYSE:CATX – Free Report) to a strong-buy rating in a research note published on Monday,Zacks.com reports. Brookline Capital ...
Tracking targeted drug delivery is often a challenge due to limitations in current imaging techniques. A recent study by ...
Good day, and welcome to the Fourth Quarter 2024 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results